SV Life Sciences Rebrands As SV Health Investors

SV Life Sciences, a Boston, MA-based healthcare and life sciences venture capital and growth equity firm, has changed its name to SV Health Investors.

The rebrands aims to better reflect the firm’s longstanding strategy and multi-sector focus of targeting early-stage opportunities in biotechnology; early-stage and revenue-stage opportunities in medical devices; and growth equity investments for later-stage businesses in healthcare services and digital health.

SV team members apply their healthcare domain expertise, operating experience and broad networks to their work with portfolio companies as hands-on advisers and partners, from formation or recapitalization to exit.

The firm, headquartered in Boston with offices in London and San Francisco, has approximately $2.0 billion of capital commitments under management with investments in over 175 companies over the past 20 years.

FinSMEs

10/04/2017

Join the discussion